In vivo and in vitro anti-cancer activity of thermo-sensitive and photo-crosslinkable doxorubicin hydrogels composed of chitosan–doxorubicin conjugates-Reference-Cited by-同舟云学术

In vivo and in vitro anti-cancer activity of thermo-sensitive and photo-crosslinkable doxorubicin hydrogels composed of chitosan–doxorubicin conjugates

Published:2009-09 Issue:1 Volume:73 Page:59-65
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Cho Young Il,Park Shinyoung,Jeong Seo Young,Yoo Hyuk Sang

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference34 articles.

1. Photopolymerizable hydrogel for tissue engineering applications;Nguyen;Biomaterials,2002

2. Photocrosslinkable polysaccharides for in situ hydrogel formation;Smeds;J. Biomed. Mater. Res.,2001

3. A chitosan hydrogel-based cancer drug delivery system exhibits synergistic antitumor effects by combining with a vaccinia viral vaccine;Han;Int. J. Pharm.,2008

4. Controlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent effect on subcutaneous tumor growth in mice;Obara;J. Control. Rel.,2005

5. Novel crosslinking methods to design hydrogels;Hennink;Adv. Drug. Del. Rev.,2002

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of recent advances in drug loading, mathematical modeling and applications of hydrogel drug delivery systems;Journal of Materials Science;2024-08

2. Implantation of In Situ Gelling Systems for the Delivery of Chemotherapeutic Agents;Gels;2024-01-05

3. Complete breakdown of copper-free clickable doxorubicin nanoclusters for real-time tumor proliferation tracking;Chemical Engineering Journal;2023-07

4. Photocurable Thiol–yne Alginate Hydrogels for Regenerative Medicine Purposes;Polymers;2022-11-03

5. Chitosan‐based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy;Bioengineering & Translational Medicine;2022-09-13